Nemes Rush Group LLC Acadia Pharmaceuticals Inc Transaction History
Nemes Rush Group LLC
- $809 Billion
- Q4 2024
A detailed history of Nemes Rush Group LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Nemes Rush Group LLC holds 2,000 shares of ACAD stock, worth $40,580. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$40,580
Previous $37 Million
0.76%
% of portfolio
0.0%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
316Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$870 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$283 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$245 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$177 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$148 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.28B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...